US2021215613A1PendingUtilityA1

Concentration assay

Assignee: GE HEALTHCARE BIO SCIENCES ABPriority: Jun 2, 2008Filed: Nov 2, 2020Published: Jul 15, 2021
Est. expiryJun 2, 2028(~1.8 yrs left)· nominal 20-yr term from priority
G01N 2470/10G01N 2470/04G01N 33/54373G01N 33/54306G01N 21/658G01N 21/553
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods are disclosed. An example method of determining the concentration of at least one analyte in a plurality of samples by sequentially subjecting each sample to an analysis cycle includes contacting the sample or a sample-derived solution with a sensor surface supporting a species capable of specifically binding the analyte or an analyte-binding species, detecting the amount of binding to the sensor surface, and regenerating the sensor surface to prepare it for the next analytical cycle, and based on the detected binding to the sensor surface determining the concentration of analyte in each sample using virtual calibration data calculated for each analysis cycle from real calibration data obtained by contacting the solid phase with samples containing known concentrations of analyte.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of determining the concentration of at least one analyte in a plurality of samples by sequentially subjecting each sample to an analysis cycle comprising contacting the sample or a sample-derived solution with a sensor surface supporting a species capable of specifically binding the analyte or an analyte-binding species, detecting the amount of binding to the sensor surface, and regenerating the sensor surface to prepare it for the next analytical cycle, and based on the detected binding to the sensor surface determining the concentration of analyte in each sample using virtual calibration data calculated for each analysis cycle from real calibration data obtained by contacting the solid phase with samples containing known concentrations of analyte. 
     
     
         2 . The method according to  claim 1 , wherein the virtual calibration data comprise a specific calibration curve for each cycle. 
     
     
         3 . The method according to  claim 2 , wherein the cycle specific calibration curve is calculated from virtual concentrations predicted for each cycle from the real calibration data. 
     
     
         4 . The method according to  claim 3 , wherein predicting the virtual concentrations comprise fitting the known calibration data to a model function to determine a sensor response-cycle number relationship for each calibration concentration. 
     
     
         5 . The method according to  claim 4 , wherein the model function is a standard type regression curve for ligand binding. 
     
     
         6 . The method according to  claim 4 , wherein the model function is an exponential function. 
     
     
         7 . The method according to  claim 1 , wherein the virtual calibration data comprise specific calibration coefficients for each cycle. 
     
     
         8 . The method according to  claim 7 , wherein calibration equations are calculated from the real calibration data, and virtual calibration coefficients for each cycle are predicted therefrom. 
     
     
         9 . The method according to  claim 8 , wherein predicting the virtual calibration coefficients comprise fitting the calibration data to a model function to determine values for coefficients of the model function for each cycle. 
     
     
         10 . The method according to any one of  claims 1  to  9 , wherein the real calibration data comprise data from calibrations performed at least two, preferably at least three different times during the analysis of the plurality of samples. 
     
     
         11 . The method according to  claim 9 , wherein each calibration is performed with at least two, preferably at least five to eight different concentrations. 
     
     
         12 . The method according to any one of  claims 1  to  11 , wherein the analysis cycle is based on an assay format selected from a direct assay, an inhibition assay, a competitive assay, and a sandwich assay. 
     
     
         13 . The method according to  claim 12 , wherein the analysis cycle is based on a direct type assay, and an analyte specific ligand is immobilized on the sensor surface. 
     
     
         14 . The method according to  claim 12 , wherein the analysis cycle is based on an inhibition type assay, wherein the sample is mixed with a constant amount of detecting molecule, and analyte or an analyte analogue is immobilized on the sensor surface.

Join the waitlist — get patent alerts

Track US2021215613A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.